EBV-associated lymphoproliferative disorders: Classification and treatment

被引:195
作者
Carbone, Antonino [1 ]
Gloghini, Annunziata [1 ]
Dotti, Giampietro [2 ]
机构
[1] Ist Nazl Tumori, Fdn IRCCS, Dept Pathol, I-20133 Milan, Italy
[2] Baylor Coll Med, Methodist Hosp, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
关键词
EBV; EBV-associated lymphomas; post-transplant-associated lymphoproliferative disorders; HIV-associated lymphoproliferative disorders; EBV cell-based immunotherapy;
D O I
10.1634/theoncologist.2008-0036
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Since its discovery as the first human tumor virus, Epstein-Barr virus (EBV) has been implicated in the development of a wide range of B-cell lymphoproliferative disorders, including Burkitt's lymphoma, classic Hodgkin's lymphoma, and lymphomas arising in immunocompromised individuals ( post-transplant and HIV-associated lymphoproliferative disorders). T-cell lymphoproliferative disorders that have been reported to be EBV associated include a subset of peripheral T-cell lymphomas, angioimmunoblastic T-cell lymphoma, extranodal nasal type natural killer/T-cell lymphoma, and other rare histotypes. EBV encodes a series of products interacting with or exhibiting homology to a wide variety of antiapoptotic molecules, cytokines, and signal transducers, hence promoting EBV infection, immortalization, and transformation. However, the exact mechanism by which EBV promotes oncogenesis is an area of active debate. The focus of this review is on the pathology, diagnosis, classification, and pathogenesis of EBV-associated lymphomas. Recent advances in EBV cell based immunotherapy, which is beginning to show promise in the treatment of EBV-related disorders, are discussed.
引用
收藏
页码:577 / 585
页数:9
相关论文
共 79 条
[1]  
[Anonymous], 2001, World Health Organization Classification of Tumours, Pathology, and Genetics of Tumours of Haematopoietic and Lymphoid Tissues
[2]   Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma [J].
Ansell, Stephen M. ;
Horwitz, Steven M. ;
Engert, Andreas ;
Khan, Khuda Dad ;
Lin, Thomas ;
Strair, Roger ;
Keler, Tibor ;
Graziano, Robert ;
Blanset, Diann ;
Yellin, Michael ;
Fischkoff, Steven ;
Assad, Albert ;
Borchmann, Peter .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (19) :2764-2769
[3]   Epstein-Barr virus and Hodgkin's disease: Further evidence for the three disease hypothesis [J].
Armstrong, AA ;
Alexander, FE ;
Cartwright, R ;
Angus, B ;
Krajewski, AS ;
Wright, DH ;
Lee, F ;
Kane, E ;
Jarrett, RF .
LEUKEMIA, 1998, 12 (08) :1272-1276
[4]   Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas [J].
Ballester, B ;
Ramuz, O ;
Gisselbrecht, C ;
Doucet, G ;
Loï, L ;
Loriod, B ;
Bertucci, F ;
Bouabdallah, R ;
Devilard, E ;
Carbuccia, N ;
Mozziconacci, MJ ;
Birnbaum, D ;
Brousset, P ;
Berger, F ;
Salles, G ;
Briére, J ;
Houlgatte, R ;
Gaulard, P ;
Xerri, L .
ONCOGENE, 2006, 25 (10) :1560-1570
[5]  
Baumforth KRN, 1999, J CLIN PATHOL-MOL PA, V52, P307
[6]  
BORISCH B, 2001, WHO CLASSIFICATION T, P257
[7]  
BOYLE MJ, 1993, BLOOD, V81, P468
[8]   AIDS-related lymphomas: from pathogenesis to pathology [J].
Carbone, A ;
Gloghini, A .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (05) :662-670
[9]  
Carbone A, 1999, BLOOD, V93, P2319
[10]   EXPRESSION OF FUNCTIONAL CD30 ANTIGEN ON REED-STERNBERG CELLS AND HODGKINS-DISEASE CELL-LINES [J].
CARBONE, A ;
GLOGHINI, A ;
GATTEI, V ;
ALDINUCCI, D ;
DEGAN, M ;
DEPAOLI, P ;
ZAGONEL, V ;
PINTO, A .
BLOOD, 1995, 85 (03) :780-789